MIR4797: A Potential Drug Target and Biomarker (G100616216)
MIR4797: A Potential Drug Target and Biomarker
MIR4797 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoskeletal proteins, known as the intermediate filament proteins. MIR4797 is characterized by its unique structure, which consists of a long amino acid sequence followed by a short helix and a long terminal filament.
MIR4797 functions as a protein that can interact with various transcription factors, including NF-kappa-B, p53, and SMAD. It has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.
One of the most promising aspects of MIR4797 is its potential as a drug target. The MIR4797 protein has been shown to interact with various small molecules, including inhibitors of NF-kappa-B signaling. This suggests that MIR4797 may be an effective target for drugs that are designed to inhibit the activity of this transcription factor.
In addition to its potential as a drug target, MIR4797 has also been shown to be a potential biomarker. The expression of MIR4797 has been shown to be regulated by various factors, including DNA methylation and histone modifications. This suggests that MIR4797 expression may be a useful biomarker for diseases that are characterized by disruptions in these processes, such as cancer.
Another potential application of MIR4797 is its use as a therapeutic agent. The MIR4797 protein has been shown to be expressed in various tissues of the body, including the brain, heart, and kidneys. This suggests that it may be a potential target for therapies that are designed to deliver drugs or other therapeutic agents to these tissues.
In conclusion, MIR4797 is a protein that has the potential to be a drug target and biomarker. Its unique structure and function make it an attractive target for researchers who are working to develop new therapies for a variety of diseases. Further research is needed to fully understand the role of MIR4797 in cellular processes and its potential as a therapeutic agent.
Protein Name: MicroRNA 4797
The "MIR4797 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4797 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1 | MIR516B2 | MIR517A | MIR517B | MIR517C | MIR5186 | MIR5187 | MIR5188 | MIR5189 | MIR518A1 | MIR518A2 | MIR518B | MIR518C | MIR518D | MIR518E | MIR518F | MIR5190 | MIR5191 | MIR5192 | MIR5193 | MIR5194
